American Skullcap (Scutellaria lateriflora): A Randomised, Double-Blind Placebo-Controlled Crossover Study of its Effects on Mood in Healthy Volunteers

被引:18
|
作者
Brock, Christine [1 ]
Whitehouse, Julie [2 ]
Tewfik, Ihab [3 ]
Towell, Tony [4 ]
机构
[1] Univ Westminster, Sch Life Sci, London W1W 6UW, England
[2] Univ Westminster, Sch Life Sci, Dept Complementary Med, London W1W 6UW, England
[3] Univ Westminster, Sch Life Sci, Dept Human & Hlth Sci, London W1W 6UW, England
[4] Univ Westminster, Sch Social Sci Humanities & Languages, Dept Psychol, London W1B 2UW, England
关键词
American skullcap; Scutellaria lateriflora; phytotherapy; anxiety; mood states; clinical trial; ANXIETY; BAICALENSIS; DEPRESSION; EFFICACY; MEDICINE; FLAVONES; BINDING;
D O I
10.1002/ptr.5044
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Scutellaria lateriflora, a traditional herbal remedy for stress and anxiety, was tested on human volunteers for its effects on mood. In a placebo-controlled, double-blind, crossover study, 43 healthy participants were randomised to a sequence of three times daily S. lateriflora (350 mg) or placebo, each over two weeks. In this relatively non-anxious population (81% were mildly anxious or less, i.e. Beck Anxiety Inventory (BAI) scores15), there was no significant difference between skullcap and placebo with BAI (p=0.191). However, there was a significant group effect (p=0.049), suggesting a carryover effect of skullcap. For Total Mood Disturbance measured by the Profile of Mood States, there was a highly significant (p=<0.001) decrease from pre-test scores with skullcap but not placebo (p=0.072). The limitations of carryover effect, generally low anxiety scores and differences in anxiety levels between groups at baseline (p=0.022), may have reduced the chances of statistical significance in this study. However, as S. lateriflora significantly enhanced global mood without a reduction in energy or cognition, further study assessing its putative anxiolytic effects in notably anxious subjects with co-morbid depression is warranted. Copyright (c) 2013 John Wiley & Sons, Ltd.
引用
收藏
页码:692 / 698
页数:7
相关论文
共 50 条
  • [31] A PLACEBO-CONTROLLED, DOUBLE-BLIND CROSSOVER STUDY OF FLUOXETINE IN TRICHOTILLOMANIA
    CHRISTENSON, GA
    MACKENZIE, TB
    MITCHELL, JE
    CALLIES, AL
    AMERICAN JOURNAL OF PSYCHIATRY, 1991, 148 (11): : 1566 - 1571
  • [32] Cognitive and Mood Effects of a Nutrient Enriched Breakfast Bar in Healthy Adults: A Randomised, Double-Blind, Placebo-Controlled, Parallel Groups Study
    Kennedy, David O.
    Wightman, Emma L.
    Forster, Joanne
    Khan, Julie
    Haskell-Ramsay, Crystal F.
    Jackson, Philippa A.
    NUTRIENTS, 2017, 9 (12):
  • [33] Chronic escitalopram in healthy volunteers has specific effects on reinforcement sensitivity: a double-blind, placebo-controlled semi-randomised study
    Langley, Christelle
    Armand, Sophia
    Ozenne, Brice
    Johnson, Annette
    Borgsted, Camilla
    Savulich, George
    Luo, Qiang
    Cardinal, Rudolf
    Robbins, Trevor
    Stenbaek, Dea
    Knudsen, Gitte
    Sahakian, Barbara
    NEUROPSYCHOPHARMACOLOGY, 2022, 47 : 218 - 219
  • [34] Chronic escitalopram in healthy volunteers has specific effects on reinforcement sensitivity: a double-blind, placebo-controlled semi-randomised study
    Christelle Langley
    Sophia Armand
    Qiang Luo
    George Savulich
    Tina Segerberg
    Anna Søndergaard
    Elisabeth B. Pedersen
    Nanna Svart
    Oliver Overgaard-Hansen
    Annette Johansen
    Camilla Borgsted
    Rudolf N. Cardinal
    Trevor W. Robbins
    Dea S. Stenbæk
    Gitte M. Knudsen
    Barbara J. Sahakian
    Neuropsychopharmacology, 2023, 48 : 664 - 670
  • [35] Chronic escitalopram in healthy volunteers has specific effects on reinforcement sensitivity: a double-blind, placebo-controlled semi-randomised study
    Langley, Christelle
    Armand, Sophia
    Luo, Qiang
    Savulich, George
    Segerberg, Tina
    Sondergaard, Anna
    Pedersen, Elisabeth B.
    Svart, Nanna
    Overgaard-Hansen, Oliver
    Johansen, Annette
    Borgsted, Camilla
    Cardinal, Rudolf N.
    Robbins, Trevor W.
    Stenbaek, Dea S.
    Knudsen, Gitte M.
    Sahakian, Barbara J.
    NEUROPSYCHOPHARMACOLOGY, 2023, 48 (04) : 664 - 670
  • [36] Effects of Prochlorperazine on Normal Vestibular Ocular and Perceptual Responses: A Randomised, Double-Blind, Crossover, Placebo-Controlled Study
    Patel, M.
    Nigmatullina, Y.
    Seemungal, B. M.
    Golding, J. F.
    Bronstein, A. M.
    AUDIOLOGY AND NEURO-OTOLOGY, 2014, 19 (02) : 91 - 96
  • [37] Cardiovascular and renal effects of apelin in chronic kidney disease: a randomised, double-blind, placebo-controlled, crossover study
    Chapman, Fiona A.
    Melville, Vanessa
    Godden, Emily
    Morrison, Beth
    Bruce, Lorraine
    Maguire, Janet J.
    Davenport, Anthony P.
    Newby, David E.
    Dhaun, Neeraj
    NATURE COMMUNICATIONS, 2024, 15 (01)
  • [38] A randomised, placebo-controlled, double-blind, crossover study of losartan and enalapril in patients with essential hypertension
    Fagard, R
    Lijnen, P
    Pardaens, K
    Thijs, L
    Vinck, W
    JOURNAL OF HUMAN HYPERTENSION, 2001, 15 (03) : 161 - 167
  • [39] A randomised, placebo-controlled, double-blind, crossover study of losartan and enalapril in patients with essential hypertension
    R Fagard
    P Lijnen
    K Pardaens
    L Thijs
    W Vinck
    Journal of Human Hypertension, 2001, 15 : 161 - 167
  • [40] Onabotulinum toxin A treatment of cervicogenic headache: A randomised, double-blind, placebo-controlled crossover study
    Linde, Mattias
    Hagen, Knut
    Salvesen, Oyvind
    Gravdahl, Goril Bruvik
    Helde, Grethe
    Stovner, Lars Jacob
    CEPHALALGIA, 2011, 31 (07) : 797 - 807